-
The FDA has approved aliskiren, the first of a new class of antihypertensive drugs, the oral renin inhibitors.
-
That there is a link between inflammation and atherosclerosis is no longer in dispute. Whether modulation of inflammation might change the process of atherosclerosis, or even better, reduce vascular endpoints, remains a challenging question.
-
Two recent large studies have looked at the effects of various inhaler combinations on outcomes in patients with COPD.
-
Has there been any progress in extracting information about the fetal chromosomes status from maternal blood samples?
-
E3N is a French prospective cohort study initiated in 1990. The participants are members of an insurance plan that covers mostly teachers.
-
Human Papilloma Virus (HPV) infection is the most common sexually transmitted disease in US women. Its prevalence rises sharply after sexual debut and peaks between ages 20 and 29; prevalence is lower in older women.
-
-
The Women's Health Initiative (WHI) investigators conducted a secondary analysis of the two canceled clinical trial arms.
-
The Estrogen and ThromboEmbolism Risk (ESTHER) study is a case-control study performed with cases from 8 French hospitals and controls from the general population.
-
IBS-Drug Treatment Pulled, CV Side Effects; Drug Combo Better for Migraine Treatment; Pergolide Off the Market, Heart Disease Risk; Hormone Treatment, Does Timing Matter?; FDA Actions
